{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:10:22Z","timestamp":1790403022480,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["9,790,562 B2"],"award-info":[{"award-number":["9,790,562 B2"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 ES 028615-01"],"award-info":[{"award-number":["R01 ES 028615-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD 094378"],"award-info":[{"award-number":["R01 HD 094378"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD 094380"],"award-info":[{"award-number":["R01 HD 094380"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD 10036701"],"award-info":[{"award-number":["R01 HD 10036701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD 087417"],"award-info":[{"award-number":["R01HD 087417"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 MD 007602"],"award-info":[{"award-number":["U54 MD 007602"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022850","name":"Myovant Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022850","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ajog.2023.08.030","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:05:58Z","timestamp":1693681558000},"page":"662.e1-662.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8778-4447","authenticated-orcid":false,"given":"Ayman","family":"Al-Hendy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Venturella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Camilo","family":"Arjona Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Soulban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel B.","family":"Wagman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea S.","family":"Lukes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.08.030_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.maturitas.2014.06.002","article-title":"EMAS position statement: management of uterine fibroids","volume":"79","author":"P\u00e9rez-L\u00f3pez","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/j.ajog.2023.08.030_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/eurheartj\/ehq477","article-title":"Hysterectomy and risk of cardiovascular disease: a population-based cohort study","volume":"32","author":"Ingelsson","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ajog.2023.08.030_bib3","first-page":"CD003855","article-title":"Surgery versus medical therapy for heavy menstrual bleeding","volume":"2016","author":"Marjoribanks","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.08.030_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2217\/whe.15.87","article-title":"Hysterectomy for heavy menstrual bleeding","volume":"12","author":"van der Meij","year":"2016","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.ajog.2023.08.030_bib5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GME.0000000000001043","article-title":"Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study","volume":"25","author":"Laughlin-Tommaso","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2023.08.030_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/1471-0528.14383","article-title":"Medical therapies for heavy menstrual bleeding in women with uterine fibroids: a retrospective analysis of a large commercially insured population in the USA","volume":"124","author":"Yao","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.08.030_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000369390","article-title":"Combined oral contraceptive for treatment of women with uterine fibroids and abnormal uterine bleeding: a systematic review","volume":"79","author":"Moroni","year":"2015","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.ajog.2023.08.030_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1055\/s-0037-1607264","article-title":"Uterine fibroids: burden and unmet medical need","volume":"35","author":"Al-Hendy","year":"2017","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2023.08.030_bib12","doi-asserted-by":"crossref","unstructured":"Duijkers I, Migoya EM, Arjona Ferreira JC, Klipping C. Characterization of pituitary and ovarian hormone concentrations during treatment with relugolix combination therapy. Fertil Steril. 2020;114 (suppl):E81.","DOI":"10.1016\/j.fertnstert.2020.08.248"},{"key":"10.1016\/j.ajog.2023.08.030_bib13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s40262-023-01269-9","article-title":"A randomized open-label study of relugolix alone or relugolix combination therapy in premenopausal women","volume":"62","author":"Lukes","year":"2023","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2023.08.030_bib14","first-page":"373","article-title":"Norethindrone acetate and estradiol-induced endometrial hyperplasia","volume":"96","author":"Kurman","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.08.030_bib15","first-page":"323","article-title":"Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group","volume":"94","author":"Archer","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.08.030_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJMoa2008283","article-title":"Treatment of uterine fibroid symptoms with relugolix combination therapy","volume":"384","author":"Al-Hendy","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.08.030_bib19","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/AOG.0000000000004988","article-title":"Long-term relugolix combination therapy for symptomatic uterine leiomyomas","volume":"140","author":"Al-Hendy","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.08.030_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3109\/00016346609158455","article-title":"Menstrual blood loss\u2014a population study. Variation at different ages and attempts to define normality","volume":"45","author":"Hallberg","year":"1966","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2023.08.030_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1055\/s-0031-1287662","article-title":"The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding","volume":"29","author":"Fraser","year":"2011","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ajog.2023.08.030_bib24","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.jval.2022.06.005","article-title":"Development of the bleeding and pelvic discomfort scale for use in women with heavy menstrual bleeding associated with uterine fibroids","volume":"25","author":"Hudgens","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.ajog.2023.08.030_bib25","doi-asserted-by":"crossref","first-page":"320.e1","DOI":"10.1016\/j.ajog.2022.11.1278","article-title":"Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials","volume":"228","author":"Stewart","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"62","key":"10.1016\/j.ajog.2023.08.030_bib26","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.japh.2022.02.004","article-title":"Systematic review of oral pharmacotherapeutic options for the management of uterine fibroids","author":"Rovelli","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.ajog.2023.08.030_bib27","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000004401","article-title":"Management of symptomatic uterine leiomyomas: ACOG practice bulletin, number 228","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.08.030_bib28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1056\/NEJMoa1904351","article-title":"Elagolix for heavy menstrual bleeding in women with uterine fibroids","volume":"382","author":"Schlaff","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.08.030_bib29","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/AOG.0000000000003869","article-title":"Elagolix treatment for UP to 12 months in women with heavy menstrual bleeding and uterine leiomyomas","volume":"135","author":"Simon","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.08.030_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/M15-0288","article-title":"International Society for Medical Publication Professionals. Good publication practice for communicating company-sponsored medical research: GPP3","volume":"163","author":"Battisti","year":"2015","journal-title":"Ann Intern Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823006002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823006002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:44:25Z","timestamp":1757591065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823006002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0002937823006002"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.08.030","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}